EDIT vs XRAY · rev $32.3M vs rev $3.68B
Editas Medicine Inc (EDIT) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
EDIT currently screens at market cap $375.2M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the EDIT and XRAY stock pages for the full models.
Not investment advice.